Most dental marketing conversations start and end with new patient acquisition — SEO, Google Ads, referral programs, reviews. It's the default place practices put their budget. Patient acquisition cost dental practices track closely, and for good reason: new patients are the visible engine of growth.
But there's a second growth channel sitting quietly in every practice's system. It costs a fraction as much, and most practices barely touch it. Here's the real math on both, so you can see where your next marketing dollar actually goes furthest.
Patient Acquisition Cost Dental Practices Are Paying Right Now
Patient acquisition cost (sometimes called PAC or CPA) measures the total marketing spend required to get one new patient into your chair. That's not just a lead or an inquiry — it's someone who actually shows up and becomes a patient. In recent industry data, that number typically falls between $150 and $400 per patient. Location and channel drive most of the variation. Suburban practices tend to sit at the lower end. Competitive metro markets often push toward the higher end, or beyond. Google Ads tends to run higher per patient than SEO or referrals, which are the cheapest channels once they're established.
That cost only makes sense next to what a patient is worth over time. A general preventive patient's lifetime value tends to run $3,000-5,000 over several years of regular visits. Higher-value cases, like implants or cosmetic work, can push lifetime value much higher. So even at $400 to acquire, a patient worth $4,000+ over their lifetime is still a strong return. That's exactly why new patient marketing keeps getting funded. It works. It's just not the whole picture.
What It Costs to Bring Back a Lapsed Patient
Reactivation means reaching out to patients who've gone quiet and getting them rebooked. It runs on a completely different cost structure. Recent estimates put the cost to reactivate a dormant patient at roughly a tenth, or less, of what it costs to acquire a new one. One widely cited figure puts new patient acquisition around $312, against a reactivation cost of roughly $12 — over a 25x difference.
Why is the gap this wide? It isn't complicated. A lapsed patient already trusts your practice. They've been in the chair, and they're already in your system. No advertising spend is required to reach them — just outreach. In other words, the acquisition work is already done. What's missing is follow-up.
The Real Comparison
Put side by side, the math is stark. Acquiring a new patient can cost 10-25 times more than reactivating one who already knows your practice. That doesn't mean new patient marketing is a bad investment — a healthy practice needs both new growth and retained growth to actually expand.
But it does mean something important: a recall list full of lapsed patients is one of the least expensive growth opportunities most practices have sitting untouched. And it's frequently ignored, in favor of pouring more budget into acquisition channels that already cost far more per patient gained.
Here's a useful gut check. If your practice is spending steadily on new patient marketing while your recall list hasn't been worked in months, you're likely paying a premium for growth that a fraction of that budget, redirected toward reactivation, could produce more cheaply.
Why Reactivation Gets Ignored Anyway
If the math is this favorable, why does reactivation get so little attention? Mostly because it isn't a line item the way ad spend is. Nobody has to approve a budget to "not work the recall list" — it just doesn't happen. There's usually no dedicated time or team assigned to it. New patient marketing gets a budget and a vendor. Reactivation usually gets neither, even though the return on the effort is better.
This is exactly the gap a dedicated recall and reactivation team closes. Companies like Full-Schedule exist specifically to make sure the cheaper growth channel actually gets worked, the same way a marketing agency makes sure ad spend gets managed.
Where Your Next Dollar Should Actually Go
For most practices, the answer isn't "stop acquiring new patients." It's "make sure reactivation gets attention proportional to how cheap and effective it is." A practice with a large, unworked recall list usually has more near-term growth sitting in that list than in the next marketing campaign — at a fraction of the cost per patient recovered.
The Bottom Line
New patient acquisition and reactivation aren't competing priorities. They're complementary ones. But they're rarely funded proportionally to their actual returns. Acquisition costs more and gets most of the attention. Reactivation costs far less and often gets none. The practices growing most efficiently tend to be the ones working both, not just the one that shows up as a line item on a marketing invoice.
If your recall list has grown past the point your team has time to work it, Full-Schedule is built to close that gap. It's a dedicated team handling reactivation and recall, with guaranteed appointment counts and a credit if targets aren't hit. [See how it works and what's included at each tier →]
Want a second set of hands on recall and follow-up?
If this article sounds familiar, we can talk through the actual list work sitting in your office today.
You can also review our service lineup, compare pricing, or see how the workflow works.
